Ownership
Private
Stage
Other
Modalities
Oligonucleotide therapeuticsAdoptive cell therapyGene therapy

BioDecade General Information

Consulting firm focused on biotechnology equity research, particularly in oligonucleotide, cell and gene therapies

Contact Information

Website
Primary Industry
[ "Consulting", "Investors" ]
Corporate Office

Drug Pipeline

No pipeline data available

For full access to BioDecade's pipeline data

Book a demo

Key Partnerships

No partnerships listed

Need more data on over 80,000 life science companies, including over 1200 biotechs?

Book a demo

BioDecade Funding

No funding data available

Early Stage VC (Series A)04-Jun-2020$38MCompletedPhase 1
Seed Round12-Feb-2019$8.5MCompletedStartup

Interested in comprehensive profile data?

We'll help you find what you need

Learn more
To view BioDecade's complete valuation and funding history, request access »